| SpectraBase Spectrum ID |
IrwBeTC4qPb |
| Name |
1-(3-Bromobenzyl)-4-(2-hydroxyethyl)piperazine |
| Classification |
Piperazine designer drug |
| Copyright |
Copyright © 2024-2025 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
298.068076239 u |
| Formula |
C13H19BrN2O |
| InChI |
InChI=1S/C13H19BrN2O/c14-13-3-1-2-12(10-13)11-16-6-4-15(5-7-16)8-9-17/h1-3,10,17H,4-9,11H2 |
| InChIKey |
BAMYAEXJRNQESW-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
299.212 g/mol |
| Nominal Mass |
298 u |
| Quality |
932 |
| Retention Index |
2095 |
| SMILES |
OCCN1CCN(CC=2C=C(C=CC2)Br)CC1 |
| SPLASH |
splash10-01bc-9350000000-d90cc2c354cddaebdef4 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Piperazine,1-(3-bromobenzyl)-4-(2-hydroxyethyl)
2-(4-(3-bromobenzyl)piperazin-1-yl)ethan-1-ol |
| Technique |
GC/MS |
| Wiley ID |
DD2024_011234 |
